{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:52:36Z","timestamp":1792090356007,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1038\/71691","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:50:09Z","timestamp":1027673409000},"page":"57-60","source":"Crossref","is-referenced-by-count":345,"title":["Reversibility of acute B-cell leukaemia induced by BCR\u2013ABL1"],"prefix":"10.1038","volume":"24","author":[{"given":"Claudia S.","family":"Huettner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Van Etten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Tenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng0100_57_CR1","first-page":"1197","volume":"132","author":"PC Nowell","year":"1960","unstructured":"Nowell, P.C. & Hungerford, D.A. A minute chromosome in human chronic granulocytic leukemia. Science 132, 1197\u20131200 (1960).","journal-title":"Science"},{"key":"BFng0100_57_CR2","first-page":"751","volume":"10","author":"JV Melo","year":"1996","unstructured":"Melo, J. V. The molecular biology of chronic myeloid leukaemia. Leukemia 10, 751\u2013756 (1996).","journal-title":"Leukemia"},{"key":"BFng0100_57_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/315550a0","volume":"315","author":"E Shtivelman","year":"1985","unstructured":"Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550\u2013554 (1985).","journal-title":"Nature"},{"key":"BFng0100_57_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1126\/science.3422516","volume":"239","author":"SS Clark","year":"1988","unstructured":"Clark, S.S. et al. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239, 775\u2013777 (1988).","journal-title":"Science"},{"key":"BFng0100_57_CR5","first-page":"294","volume-title":"Leukemia: Advances in Treatment and Research","author":"RA Van Etten","year":"1993","unstructured":"Van Etten, R.A. in Leukemia: Advances in Treatment and Research (eds Freireich, E.J. & Kantarjian, H.) 294\u2013325 (Kluwer Academic, Norwood, 1993)."},{"key":"BFng0100_57_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp, N., et al. Acute leukaemia in bcr\/abl transgenic mice. Nature 344, 251\u2013253 (1990).","journal-title":"Nature"},{"key":"BFng0100_57_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02512996","volume":"1","author":"N Heisterkamp","year":"1991","unstructured":"Heisterkamp, N., Jenster, G., Kioussis, D., Pattengale, P.K. & Groffen, J. Human bcr-abl gene has a lethal effect on embryogenesis. Transgenic Res. 1, 45\u201353 (1991).","journal-title":"Transgenic Res."},{"key":"BFng0100_57_CR8","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1182\/blood.V85.10.2853.bloodjournal85102853","volume":"85","author":"H Honda","year":"1995","unstructured":"Honda, H., et al. Expression of p210bcr\/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85, 2853\u20132861 (1995).","journal-title":"Blood"},{"key":"BFng0100_57_CR9","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V91.6.2067","volume":"91","author":"H Honda","year":"1998","unstructured":"Honda, H., et al. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210(bcr\/abl): a novel transgenic model for human Ph1-positive leukemias. Blood 91, 2067\u20132075 (1998).","journal-title":"Blood"},{"key":"BFng0100_57_CR10","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1182\/blood.V90.6.2168","volume":"90","author":"A Castellanos","year":"1997","unstructured":"Castellanos, A., et al. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90, 2168\u20132174 (1997).","journal-title":"Blood"},{"key":"BFng0100_57_CR11","doi-asserted-by":"publisher","first-page":"9302","DOI":"10.1073\/pnas.91.20.9302","volume":"91","author":"PA Furth","year":"1994","unstructured":"Furth, P.A., et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl Acad. Sci. USA 91, 9302\u20139306 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0100_57_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/jcb.240590407","volume":"59","author":"L Hennighausen","year":"1995","unstructured":"Hennighausen, L., Wall, R.J., Tillmann, U., Li, M. & Furth, P.A. Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV-LTR and the tetracycline responsive system. J. Cell. Biochem. 59, 463\u2013472 (1995).","journal-title":"J. Cell. Biochem."},{"key":"BFng0100_57_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.173.5.1213","volume":"173","author":"RR Hardy","year":"1991","unstructured":"Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213\u20131225 (1991).","journal-title":"J. Exp. Med."},{"key":"BFng0100_57_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0378-1119(98)00491-0","volume":"222","author":"HS Radomska","year":"1998","unstructured":"Radomska, H.S. et al. Multiple control elements are required for expression of the human CD34 gene. Gene 222, 305\u2013318 (1998).","journal-title":"Gene"},{"key":"BFng0100_57_CR15","first-page":"77","volume-title":"Medical Management of Chronic Myelogenous Leukemia","author":"RA Van Etten","year":"1998","unstructured":"Van Etten, R.A. in Medical Management of Chronic Myelogenous Leukemia (eds Talpaz, M. & Kantarjian, H.) 77\u2013101 (Marcel Dekker, New York, 1998)."},{"key":"BFng0100_57_CR16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","volume":"83","author":"A McGahon","year":"1994","unstructured":"McGahon, A., et al. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83, 1179\u20131187 (1994).","journal-title":"Blood"},{"key":"BFng0100_57_CR17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","volume":"83","author":"A Bedi","year":"1994","unstructured":"Bedi, A., Zehnbauer, B.A., Barber, J.P., Sharkis, S.J. & Jones, R.J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83, 2038\u20132044 (1994).","journal-title":"Blood"},{"key":"BFng0100_57_CR18","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1073\/pnas.89.15.6683","volume":"89","author":"YY Chen","year":"1992","unstructured":"Chen, Y.Y. & Rosenberg, N. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1. Proc. Natl Acad. Sci. USA 89, 6683\u20136687 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0100_57_CR19","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1126\/science.273.5280.1384","volume":"273","author":"D Ewald","year":"1996","unstructured":"Ewald, D., et al. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273, 1384\u20131386 (1996).","journal-title":"Science"},{"key":"BFng0100_57_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker, B.J., et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2, 561\u2013566 (1996).","journal-title":"Nature Med."},{"key":"BFng0100_57_CR21","doi-asserted-by":"publisher","first-page":"11335","DOI":"10.1073\/pnas.88.24.11335","volume":"88","author":"GQ Daley","year":"1991","unstructured":"Daley, G.Q., Van Etten, R.A. & Baltimore, D. Blast crisis in a murine model of chronic myelogenous leukemia. Proc. Natl Acad. Sci. USA 88, 11335\u201311338 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0100_57_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0092-8674(90)90589-7","volume":"60","author":"M Tanaka","year":"1990","unstructured":"Tanaka, M. & Herr, W. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60, 375\u2013386 (1990).","journal-title":"Cell"},{"key":"BFng0100_57_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2141.1993.tb03026.x","volume":"84","author":"NC Cross","year":"1993","unstructured":"Cross, N.C., et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. Br. J. Haematol. 84, 67\u201374 (1993).","journal-title":"Br. J. Haematol."},{"key":"BFng0100_57_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1084\/jem.158.1.192","volume":"158","author":"E Kraig","year":"1983","unstructured":"Kraig, E., et al. T and B cells that recognized the same antigen do not transcribe similar heavy chain variable region gene segments. J. Exp. Med. 158, 192\u2013209 (1983).","journal-title":"J. Exp. Med."},{"key":"BFng0100_57_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0092-8674(86)90280-1","volume":"45","author":"A Leder","year":"1986","unstructured":"Leder, A., Pattengale, P.K., Kuo, A., Stewart, T.A. & Leder, P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45, 485\u2013495 (1986).","journal-title":"Cell"},{"key":"BFng0100_57_CR26","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood.V86.10.3897.bloodjournal86103897","volume":"86","author":"RL Ilaria Jr","year":"1995","unstructured":"Ilaria, R.L. Jr & Van Etten, R.A. The SH2 domain of P210BCR\/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood 86, 3897\u20133904 (1995).","journal-title":"Blood"},{"key":"BFng0100_57_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119, 493\u2013501 (1992).","journal-title":"J. Cell. Biol."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0100_57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0100_57","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0100_57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:15:21Z","timestamp":1684440921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0100_57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["BFng0100_57"],"URL":"https:\/\/doi.org\/10.1038\/71691","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}